GeneDx Holdings (WGSWW) Share-based Compensation (2020 - 2026)

GeneDx Holdings has disclosed Share-based Compensation across 7 years of filings, most recently posting $9.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 125.86% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $37.2 million (up 173.91% YoY), while the FY2025 annual figure was $32.2 million, up 251.96% from the prior year.
• Share-based Compensation eased to $9.0 million in Q1 2026, from $9.8 million in the prior quarter.
• Over the last five years, Share-based Compensation for WGSWW reached as high as $22.7 million in Q2 2022 and fell as low as -$912000.0 in Q4 2023.
• The 5-year median for Share-based Compensation is $3.1 million (2024), against an average of $5.4 million.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 4477.84% — and 2024, when it tumbled 1039.58%.
• A 5-year view of Share-based Compensation shows it stood at $422000.0 in 2022, then slumped by 316.11% to -$912000.0 in 2023, then soared by 411.95% to $2.8 million in 2024, then soared by 243.76% to $9.8 million in 2025, then fell by 8.02% to $9.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $9.0 million, $9.8 million, and $10.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.